Gan & Lee Pharmaceuticals. (SHA:603087)
China flag China · Delayed Price · Currency is CNY
56.70
+2.62 (4.84%)
Jun 18, 2026, 3:00 PM CST

SHA:603087 Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, SHA:603087 stock has a consensus rating of "Strong Buy" and an average price target of ¥72.50. The average 1-year stock price forecast is 27.87% higher than the current stock price, while the lowest is ¥68.00 (+19.93%) and the highest is ¥77.00 (+35.80%).

Price Target: ¥72.50 (+27.87%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price¥68.00¥72.50¥72.50¥77.00
Change+19.93%+27.87%+27.87%+35.80%

Analyst Ratings

The average analyst rating for SHA:603087 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Mar '26Apr '26May '26
Strong Buy333223
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total444334

Financial Forecast

Revenue This Year
4.73B
from 4.05B
Increased by 16.64%
Revenue Next Year
5.53B
from 4.73B
Increased by 17.06%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
3.61B1.71B2.61B3.05B4.05B4.73B
Revenue Growth
7.44%-52.60%52.32%16.77%33.06%16.64%
Gross Profit
3.21B1.27B1.88B2.27B3.07B3.56B
Gross Margin
88.93%74.07%72.21%74.48%75.68%75.40%
Operating Income
1.39B-675.68M180.03M294.58M759.74M1.49B
Net Income
1.45B-439.52M340.07M614.66M1.14B1.39B
Dividend / Share
0.30-0.201.501.000.24
Dividend Growth
---650.00%-33.33%-76.00%
No. Analysts
-----3
Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High4.8B
Avg4.7B
Low4.7B

Revenue Growth

Revenue Growth202620272028
High
17.8%
Avg
16.6%
Low
14.8%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-